Dose–response for inhaled fluticasone on airway and systemic inflammation in COPD Source: Eur Respir J 2011; 37: 206-209 Year: 2011
Airway inflammation and inhaled corticosteroids in COPD Source: Eur Respir J, 49 (6) 1700289; 10.1183/13993003.00289-2017 Year: 2017
Airway inflammation in COPD after long-term withdrawal of inhaled corticosteroids Source: Eur Respir J 2017; 49(1): 1600839; DOI: 10.1183/13993003.00839-2016 Year: 2017
Airway inflammation in COPD after long-term withdrawal of inhaled corticosteroids Source: Eur Respir J, 49 (6) 1700848; 10.1183/13993003.00848-2017 Year: 2017
Effects of fluticasone and ciclesonide on pulmonary function and airway inflammation in stable mild asthmatics Source: Annual Congress 2009 - Aspects of clinical asthma Year: 2009
Rapid protective effect of inhaled fluticasone on airway hyperresponsiveness to AMP in patients with fixed airway obstruction due to asthma but not COPD Source: Eur Respir J 2006; 28: Suppl. 50, 670s Year: 2006
Dissociation in effects of fluticasone but not fluticasone/salmeterol on lung function and airway hyperresponsiveness in mild persistent asthma Source: Eur Respir J 2002; 20: Suppl. 38, 385s Year: 2002
Response to fluticasone propionate in controlling airway inflammation in steroid-naïve asthma patients Source: Eur Respir J 2006; 28: Suppl. 50, 317s Year: 2006
Acute protective effect of inhaled fluticasone on airway hyperresponsiveness to adenosine 5’-monophosphate in asthma but not in chronic obstructive pulmonary disease Source: Eur Respir J 2004; 24: Suppl. 48, 442s Year: 2004
Evaluation of the effect of inhaled ciclesonide on inflammatory and allergic markers and pulmonary function in bronchial asthma Source: Annual Congress 2008 - Improving asthma and anti-allergic therapy Year: 2008
Assessment of bronchial hyperreactivity, maximal airway response and response to inhaled corticosteriod treatment in patients with bronchiectasis Source: Annual Congress 2007 - Current issues in airway physiology, pharmacology and monitoring Year: 2007
Stable COPD: predicting benefit from high-dose inhaled corticosteroid treatment Source: Eur Respir J 2006; 27: 964-971 Year: 2006
Blood eosinophils predict inhaled fluticasone response in bronchiectasis Source: Eur Respir J, 56 (2) 2000453; 10.1183/13993003.00453-2020 Year: 2020
Inhaled budesonide suppresses airway and systemic eosinophilic inflammation in COPD. No predictive value of a prednisolone test treatment Source: Eur Respir J 2005; 26: Suppl. 49, 290s Year: 2005
Sustained reduction of bronchial hyperresponsiveness with inhaled fluticasone propionate in mild asthma within three days Source: Eur Respir J 2002; 20: Suppl. 38, 197s Year: 2002
Reducing the dose of inhaled corticosteroids (ICS) under therapy with montelukast in stable asthma: effects on lung function and inflammation Source: Eur Respir J 2001; 18: Suppl. 33, 261s Year: 2001
Dose reduction of inhaled corticosteroids under concomitant medication with montelukast in patients with asthma Source: Eur Respir J 2002; 20: 1080-1087 Year: 2002
Effects of inhaled corticosteroids on asthmatic inflammation: The FeNOtype trial Source: Annual Congress 2012 - Asthma treatment: efficacy and safety Year: 2012
Obesity and the response to inhaled budesonide in patients with asthma Source: Annual Congress 2007 - Asthma subphenotypes Year: 2007
Effect of add-on montelukast to inhaled corticosteroids on excessive airway narrowing in adult asthmatics Source: Annual Congress 2009 - Aspects of clinical asthma Year: 2009